|
|
||||||||








* Department of Immunology, Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, Japan;
Department of Microbiology and Immunology, Graduate School of Medicine, Hokkaido University, Sapporo, Japan;
Genome Information Research Center, Osaka University, Suita, Osaka, Japan;
Department of Virology, Osaka City University Medical School, Osaka, Japan; and
¶
Department of Immunology, Graduate School of Medicine and Faculty of Medicine, University of Tokyo, Tokyo, Japan
We generated transgenic (TG) mice that constitutively express human CD46 (huCD46) and/or TLR-inducible CD150 (huCD150), which serve as receptors for measles virus (MV). These mice were used to study the spreading and pathogenicity of GFP-expressing or intact laboratory-adapted Edmonston and wild-type Ichinose (IC) strains of MV. Irrespective of the route of administration, neither type of MV was pathogenic to these TG mice. However, in ex vivo, limited replication of IC was observed in the spleen lymphocytes from huCD46/huCD150 TG and huCD150 TG, but not in huCD46 TG and non-TG mice. In huCD150-positive TG mouse cells, CD11c-positive bone marrow-derived myeloid dendritic cells (mDC) participated in MV-mediated type I IFN induction. The level and induction profile of IFN-
was higher in mDC than the profile of IFN-
. Wild-type IC induced markedly high levels of IFN-
compared with Edmonston in mDC, as opposed to human dendritic cells. We then generated huCD46/huCD150 TG mice with type I IFN receptor (IFNAR1)/ mice. MV-bearing mDCs spreading to draining lymph nodes were clearly observed in these triple mutant mice in vivo by i.p. MV injection. Infectious lymph nodes were also detected in the double TG mice into which MV-infected CD11c-positive mDCs were i.v. transferred. This finding suggests that in the double TG mouse model mDCs once infected facilitate systemic MV spreading and infection, which depend on mDC MV permissiveness determined by the level of type I IFN generated via IFNAR1. Although these results may not simply reflect human MV infection, the huCD150/huCD46 TG mice may serve as a useful model for the analysis of MV-dependent modulation of mDC response.
This article has been cited by other articles:
![]() |
F. Herschke, S. Plumet, T. Duhen, O. Azocar, J. Druelle, D. Laine, T. F. Wild, C. Rabourdin-Combe, D. Gerlier, and H. Valentin Cell-Cell Fusion Induced by Measles Virus Amplifies the Type I Interferon Response J. Virol., December 1, 2007; 81(23): 12859 - 12871. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Shingai, T. Ebihara, N. A. Begum, A. Kato, T. Honma, K. Matsumoto, H. Saito, H. Ogura, M. Matsumoto, and T. Seya Differential Type I IFN-Inducing Abilities of Wild-Type versus Vaccine Strains of Measles Virus J. Immunol., November 1, 2007; 179(9): 6123 - 6133. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ohno, N. Ono, F. Seki, M. Takeda, S. Kura, T. Tsuzuki, and Y. Yanagi Measles Virus Infection of SLAM (CD150) Knockin Mice Reproduces Tropism and Immunosuppression in Human Infection J. Virol., February 15, 2007; 81(4): 1650 - 1659. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Akazawa, T. Ebihara, M. Okuno, Y. Okuda, M. Shingai, K. Tsujimura, T. Takahashi, M. Ikawa, M. Okabe, N. Inoue, et al. Antitumor NK activation induced by the Toll-like receptor 3-TICAM-1 (TRIF) pathway in myeloid dendritic cells PNAS, January 2, 2007; 104(1): 252 - 257. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Yanagi, M. Takeda, and S. Ohno Measles virus: cellular receptors, tropism and pathogenesis. J. Gen. Virol., October 1, 2006; 87(Pt 10): 2767 - 2779. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Schubert, K. Moller-Ehrlich, K. Singethan, S. Wiese, W. P. Duprex, B. K. Rima, S. Niewiesk, and J. Schneider-Schaulies A mouse model of persistent brain infection with recombinant Measles virus J. Gen. Virol., July 1, 2006; 87(7): 2011 - 2019. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. I. Sellin, N. Davoust, V. Guillaume, D. Baas, M.-F. Belin, R. Buckland, T. F. Wild, and B. Horvat High Pathogenicity of Wild-Type Measles Virus Infection in CD150 (SLAM) Transgenic Mice. J. Virol., July 1, 2006; 80(13): 6420 - 6429. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Schneider-Schaulies and U. Dittmer Silencing T cells or T-cell silencing: concepts in virus-induced immunosuppression J. Gen. Virol., June 1, 2006; 87(6): 1423 - 1438. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. von Messling, N. Svitek, and R. Cattaneo Receptor (SLAM [CD150]) Recognition and the V Protein Sustain Swift Lymphocyte-Based Invasion of Mucosal Tissue and Lymphatic Organs by a Morbillivirus. J. Virol., June 1, 2006; 80(12): 6084 - 6092. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Permar, D. E. Griffin, and N. L. Letvin Immune Containment and Consequences of Measles Virus Infection in Healthy and Immunocompromised Individuals Clin. Vaccine Immunol., April 1, 2006; 13(4): 437 - 443. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |